menu
    • menu

    Company profile for Bioiberica

    Bioiberica-PSE
    News
    A study confirms bioactive peptides in Palbio®

    15 Dec 2025

    // PRESS RELEASE

    We have presented Terra-Sorb SymBiotic®

    11 Dec 2025

    // PRESS RELEASE

    ProbioPlus®, the first supplement with a triplebiotic concept

    10 Dec 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Bioiberica VB Read More

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    https://player.vimeo.com/video/791870236?h=41235b7b7e

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Related CompaniesRelated Companies

    About

    Bioiberica is a global Life Science company with over 45 years of experience developing & producing high‑value biological molecules for the pharmaceutical and nutraceutical industries. It is one of the leading Heparin API manufacturers and a key reference for other biologically derived APIs, as well as clinically backed nutraceutical ingredients targeting mobility, digestive health, and skin and beauty. With a vertically integrated European supply chain, Bioiberica guarantees high quality, safety, & full product traceability. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioibericaSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Av. Països Catalans 34, planta 2ª 08950 Esplugues de Llobregat, Barcelona
    Telephone
    Telephone
    +34 934904908
    Client Email
    Email
    healthcare@bioiberica.com
    Client Website
    Website
    https://www.bioiberica.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioiberica/
    youtube
    YouTube
    https://vimeo.com/bioiberica
    Twitter
    Twitter
    https://x.com/Bioiberica
    Contact Info
    Others

    Maria Vilar
    Strategic Marketing & Product Manager-Healthcare

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-58493.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-75499.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Biologically-Derived APIs & Nutraceutical Branded Ingredients

    read-more

      https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-21170.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Thyroid PIS

    read-more

      https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-6899.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Chondroitin Sulfate PIS

    read-more

      https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-91262.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Glucosamine PIS

    read-more

      https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-39360.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    A study confirms bioactive peptides in Palbio®
    A study confirms bioactive peptides in Palbio®

    15 Dec 2025

    // PRESS RELEASE

    https://www.bioiberica.com/en/inspiring-insights/study-confirms-bioactive-peptides-palbior-hydrolyzed-protein-animal-nutrition

    PRESS RELEASE
    15 Dec 2025
    Share Share
    We have presented Terra-Sorb SymBiotic®
    We have presented Terra-Sorb SymBiotic®

    11 Dec 2025

    // PRESS RELEASE

    https://www.bioiberica.com/en/inspiring-insights/presented-terra-sorb-symbioticr-biostimulant-world-congress-barcelona-drive

    PRESS RELEASE
    11 Dec 2025
    Share Share
    ProbioPlus®, the first supplement with a triplebiotic concept
    ProbioPlus®, the first supplement with a triplebiotic concept

    10 Dec 2025

    // PRESS RELEASE

    https://www.bioiberica.com/en/inspiring-insights/probioplusr-first-supplement-triplebiotic-concept-plus-vitamin-b12-dogs

    PRESS RELEASE
    10 Dec 2025
    Share Share
    Bioiberica expands Nucleoforce range with three new products
    Bioiberica expands Nucleoforce range with three new products

    20 Oct 2025

    // PRESS RELEASE

    https://www.bioiberica.com/en/inspiring-insights/bioiberica-unveils-three-new-products-refreshed-nucleoforcer-range-science

    PRESS RELEASE
    20 Oct 2025
    Share Share
    Bioiberica celebrates its 50th anniversary at CPHI 2025
    Bioiberica celebrates its 50th anniversary at CPHI 2025

    15 Oct 2025

    // PRESS RELEASE

    https://www.bioiberica.com/en/inspiring-insights/bioiberica-celebrates-50th-anniversary-cphi-2025-new-brand-identity

    PRESS RELEASE
    15 Oct 2025
    Share Share
    We celebrate our 50th anniversary by relaunching our brand
    We celebrate our 50th anniversary by relaunching our brand

    08 Oct 2025

    // PRESS RELEASE

    https://www.bioiberica.com/en/inspiring-insights/celebrate-50th-anniversary-relaunching-brand-identity-unveiling-new-website

    PRESS RELEASE
    08 Oct 2025
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Clinical Study to Evaluate the Anti-aging Efficacy of Dermial® (NCT05813054 DU)

    Details:

    HA Matrix is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Skin Aging.


    Lead Product(s): HA Matrix

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Dietary Supplement

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 14, 2023

    Bioiberica Company Banner

    01

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : HA Matrix

    Therapeutic Area : Dermatology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Clinical Study to Evaluate the Anti-aging Efficacy of Dermial® (NCT05813054 DU)

    Details : HA Matrix is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Skin Aging.

    Product Name : Undisclosed

    Product Type : Dietary Supplement

    Upfront Cash : Inapplicable

    April 14, 2023

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Bioiberica Joins a European Project to Develop Treatments for Complex Wounds (48391 DU)

    Details:

    Aim is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies.


    Lead Product(s): Undisclosed

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Undisclosed

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 18, 2023

    Bioiberica Company Banner

    02

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Bioiberica Joins a European Project to Develop Treatments for Complex Wounds (48391 DU)

    Details : Aim is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Inapplicable

    January 18, 2023

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health (24794 DU)

    Details:

    New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.


    Lead Product(s): Hyaluronic Acid,Collagen,Dermatan Sulfate

    Therapeutic Area: Dermatology Brand Name: Dermial

    Study Phase: PreclinicalProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 25, 2022

    Bioiberica Company Banner

    03

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate

    Therapeutic Area : Dermatology

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health (24794 DU)

    Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.

    Product Name : Dermial

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 25, 2022

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort (NCT05282992 DU)

    Details:

    Native Type Ii Collagen is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Arthralgia.


    Lead Product(s): Native Type Ii Collagen

    Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Protein

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable March 16, 2022

    Bioiberica Company Banner

    04

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Native Type Ii Collagen

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort (NCT05282992 DU)

    Details : Native Type Ii Collagen is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Arthralgia.

    Product Name : Undisclosed

    Product Type : Protein

    Upfront Cash : Inapplicable

    March 16, 2022

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    New Partnership With ByHealth in China (16461 D)

    Details:

    By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient products across the country.


    Lead Product(s): Collavant n2

    Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Protein

    Sponsor: ByHealth

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership March 11, 2022

    Bioiberica Company Banner

    05

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Collavant n2

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : ByHealth

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    New Partnership With ByHealth in China (16461 D)

    Details : By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient produ...

    Product Name : Undisclosed

    Product Type : Protein

    Upfront Cash : Undisclosed

    March 11, 2022

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare (24798 DU)

    Details:

    Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.


    Lead Product(s): Chondroitin Sulfate Sodium

    Therapeutic Area: Musculoskeletal Brand Name: CSbioactive

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 05, 2021

    Bioiberica Company Banner

    06

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Chondroitin Sulfate Sodium

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare (24798 DU)

    Details : Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.

    Product Name : CSbioactive

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    July 05, 2021

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product–Motilex HA (16462 D)

    Details:

    Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint function.


    Lead Product(s): Hyaluronic Acid,Type II Collagen

    Therapeutic Area: Musculoskeletal Brand Name: Motilex HA

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Apsen

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership April 26, 2021

    Bioiberica Company Banner

    07

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Hyaluronic Acid,Type II Collagen

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Apsen

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product–Motilex HA (16462 ...

    Details : Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint...

    Product Name : Motilex HA

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    April 26, 2021

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Laboratorios Ordesa Incorporates B-2cool®, Bioiberica’s Native Type II Collagen, in Its New Colnatur® Forte (24799 DU)

    Details:

    B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.


    Lead Product(s): Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid

    Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Protein

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 15, 2020

    Bioiberica Company Banner

    08

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Laboratorios Ordesa Incorporates B-2cool®, Bioiberica’s Native Type II Collagen, in Its New Col...

    Details : B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.

    Product Name : Undisclosed

    Product Type : Protein

    Upfront Cash : Inapplicable

    July 15, 2020

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Nestlé Health Science Partners with Bioiberica to Deliver Innovative Nutrition in Joint Health and Mobility (16463 D)

    Details:

    Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix.


    Lead Product(s): Hyaluronic Acid,Type II Collagen,Polysaccharides

    Therapeutic Area: Musculoskeletal Brand Name: Meritene Mobilis

    Study Phase: UndisclosedProduct Type: Miscellaneous

    Recipient: Nestle Health Sciences SA

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership June 16, 2020

    Bioiberica Company Banner

    09

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : Hyaluronic Acid,Type II Collagen,Polysaccharides

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Undisclosed

    Recipient : Nestle Health Sciences SA

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Nestlé Health Science Partners with Bioiberica to Deliver Innovative Nutrition in Joint Health an...

    Details : Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix.

    Product Name : Meritene Mobilis

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    June 16, 2020

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease (NCT02991235 DU)

    Details:

    PRJ212 is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Alzheimer Disease.


    Lead Product(s): PRJ212

    Therapeutic Area: Neurology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Dietary Supplement

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 13, 2016

    Bioiberica Company Banner

    10

    Bioiberica

    Spain
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

    Lead Product(s) : PRJ212

    Therapeutic Area : Neurology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Dis...

    Details : PRJ212 is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Alzheimer Disease.

    Product Name : Undisclosed

    Product Type : Dietary Supplement

    Upfront Cash : Inapplicable

    December 13, 2016

    Bioiberica Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Excipients

    Discover the DDS // excipients from this company

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Bioiberica and get a quotation

    Bioiberica is a supplier offers 11 products (APIs, Excipients or Intermediates).

    Find a price of Heparin Sodium bulk with DMF, JDMF offered by Bioiberica

    Find a price of Chondroitin Sulfate Sodium bulk with CEP offered by Bioiberica

    Find a price of Heparin Sodium bulk with DMF offered by Bioiberica

    Find a price of Chondroitin Sulfate Sodium bulk offered by Bioiberica

    Find a price of Glucosamine bulk offered by Bioiberica

    Find a price of Glucosamine Hydrochloride bulk offered by Bioiberica

    Find a price of Glucosamine Sulfate Potassium Chloride bulk offered by Bioiberica

    Find a price of Glucosamine Sulfate Sodium Chloride bulk offered by Bioiberica

    Find a price of Heparin Lithium bulk offered by Bioiberica

    Find a price of Liothyronine Sodium bulk offered by Bioiberica

    Find a price of Thyroid bulk offered by Bioiberica

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search